Arthritis Research & Therapy

official impact factor 4.36

Safety concerns on the development of novel therapeutic drugs

Caroline Ospelt* and Steffen Gay

Arthritis Research & Therapy 2006, 8:112 doi:10.1186/ar2032

Accesses  

  • Last 30 days: 32 accesses
  • Last 365 days: 268 accesses
  • All time: 1842 accesses